Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 32

  • Quoted phrase not found.

Optimized pacing mode for hypertrophic cardiomyopathy: Impact of ECG fusion during pacing.

Berruezo A, Penela D, Burgos F, Evertz R, Fernández-Armenta J, Roca J, Doltra A, Acosta J, Francino A, Sitges M, Alsina X, Ordoñez A, Villuendas R, Brugada R, Mont L, Brugada J.

Heart Rhythm. 2015 May;12(5):909-16. doi: 10.1016/j.hrthm.2015.01.032. Epub 2015 Jan 23.


Diagnosis and management of inherited cardiomyopathies.

Millar L, Sharma S.

Practitioner. 2014 Oct;258(1775):21-5, 2-3.


The Brockenbrough-Braunwald-Morrow sign.

Trevino AR, Buergler J.

Methodist Debakey Cardiovasc J. 2014 Jan-Mar;10(1):34-7.


Differences in global and regional left ventricular myocardial mechanics in various morphologic subtypes of patients with obstructive hypertrophic cardiomyopathy referred for ventricular septal myotomy/myectomy.

Kobayashi T, Dhillon A, Popovic Z, Bhonsale A, Smedira NG, Thamilarasan M, Lytle BW, Lever HM, Desai MY.

Am J Cardiol. 2014 Jun 1;113(11):1879-85. doi: 10.1016/j.amjcard.2014.03.020. Epub 2014 Mar 18.


Management of hypertrophic cardiomyopathy.

Enriquez AD, Goldman ME.

Ann Glob Health. 2014 Jan-Feb;80(1):35-45. doi: 10.1016/j.aogh.2013.12.004. Epub 2013 Dec 25. Review.


Advances in medical treatment of hypertrophic cardiomyopathy.

Hamada M, Ikeda S, Shigematsu Y.

J Cardiol. 2014 Jul;64(1):1-10. doi: 10.1016/j.jjcc.2014.02.022. Epub 2014 Apr 13. Review. Erratum in: J Cardiol. 2014 Oct;64(4):330.


Effects of lifestyle changes and high-dose β-blocker therapy on exercise capacity in children, adolescents, and young adults with hypertrophic cardiomyopathy.

Bratt EL, Östman-Smith I.

Cardiol Young. 2015 Mar;25(3):501-10. doi: 10.1017/S1047951114000237. Epub 2014 Mar 10.


Early changes in apical rotation in genotype positive children with hypertrophic cardiomyopathy mutations without hypertrophic changes on two-dimensional imaging.

Forsey J, Benson L, Rozenblyum E, Friedberg MK, Mertens L.

J Am Soc Echocardiogr. 2014 Feb;27(2):215-21. doi: 10.1016/j.echo.2013.10.012. Epub 2013 Dec 8.


A systematic review and meta-analysis of genotype-phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations.

Lopes LR, Rahman MS, Elliott PM.

Heart. 2013 Dec;99(24):1800-11. doi: 10.1136/heartjnl-2013-303939. Epub 2013 May 14. Review.


The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention.

Olde Nordkamp LR, Wilde AA, Tijssen JG, Knops RE, van Dessel PF, de Groot JR.

Circ Arrhythm Electrophysiol. 2013 Feb;6(1):91-100. doi: 10.1161/CIRCEP.112.975268. Epub 2012 Dec 29.


Pregnancy outcome and management of women with an implantable cardioverter defibrillator: a single centre experience.

Schuler PK, Herrey A, Wade A, Brooks R, Peebles D, Lambiase P, Walker F.

Europace. 2012 Dec;14(12):1740-5. doi: 10.1093/europace/eus172. Epub 2012 Jun 27.


The clinical management of relatives of young sudden unexplained death victims; implantable defibrillators are rarely indicated.

Caldwell J, Moreton N, Khan N, Kerzin-Storrar L, Metcalfe K, Newman W, Garratt CJ.

Heart. 2012 Apr;98(8):631-6. doi: 10.1136/heartjnl-2011-300924.


Long-term rescue of a familial hypertrophic cardiomyopathy caused by a mutation in the thin filament protein, tropomyosin, via modulation of a calcium cycling protein.

Gaffin RD, Peña JR, Alves MS, Dias FA, Chowdhury SA, Heinrich LS, Goldspink PH, Kranias EG, Wieczorek DF, Wolska BM.

J Mol Cell Cardiol. 2011 Nov;51(5):812-20. doi: 10.1016/j.yjmcc.2011.07.026. Epub 2011 Aug 5.


Genetic screening and double mutation in Japanese patients with hypertrophic cardiomyopathy.

Kubo T, Kitaoka H, Okawa M, Baba Y, Hirota T, Hayato K, Yamasaki N, Matsumura Y, Otsuka H, Arimura T, Kimura A, Doi YL.

Circ J. 2011;75(11):2654-9. Epub 2011 Jul 29.


Negative ionotropic agents for the treatment of left ventricular outflow tract obstruction due to sigmoid septum and concentric left ventricular hypertrophy.

Ranasinghe I, Yeoh T, Yiannikas J.

Heart Lung Circ. 2011 Sep;20(9):579-86. doi: 10.1016/j.hlc.2011.05.002. Epub 2011 Jun 17.


Neonatal gene transfer of Serca2a delays onset of hypertrophic remodeling and improves function in familial hypertrophic cardiomyopathy.

Peña JR, Szkudlarek AC, Warren CM, Heinrich LS, Gaffin RD, Jagatheesan G, del Monte F, Hajjar RJ, Goldspink PH, Solaro RJ, Wieczorek DF, Wolska BM.

J Mol Cell Cardiol. 2010 Dec;49(6):993-1002. doi: 10.1016/j.yjmcc.2010.09.010. Epub 2010 Sep 18.


The binary endocardial appearance is a poor discriminator of Anderson-Fabry disease from familial hypertrophic cardiomyopathy.

Kounas S, Demetrescu C, Pantazis AA, Keren A, Lee PJ, Hughes D, Mehta A, Elliott PM.

J Am Coll Cardiol. 2008 May 27;51(21):2058-61. doi: 10.1016/j.jacc.2008.02.046.


Age- and gender-specific mortality rates in childhood hypertrophic cardiomyopathy.

Ostman-Smith I, Wettrell G, Keeton B, Holmgren D, Ergander U, Gould S, Bowker C, Verdicchio M.

Eur Heart J. 2008 May;29(9):1160-7. doi: 10.1093/eurheartj/ehn122. Epub 2008 Apr 2.


Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice.

Okazaki T, Tanaka Y, Nishio R, Mitsuiye T, Mizoguchi A, Wang J, Ishida M, Hiai H, Matsumori A, Minato N, Honjo T.

Nat Med. 2003 Dec;9(12):1477-83. Epub 2003 Nov 2.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk